Zipalertinib plus chemotherapy significantly extends progression-free survival in first-line EGFR lung cancer

(+contact-url) Example: MyBot/1.0 (+https://example.com/contact) If you have a legitimate interest in crawling our site, please contact us to request whitelisting. Properly identified bots may be granted access without going through this verification process. IMPORTANT: Your bot MUST respect HTTP 429 (Too Many Requests) response headers and implement proper rate limiting. Failure to do so may result in blocking. For questions or whitelisting requests, please use our contact form. --> Checking your connection 🛡️ Just a quick check We’re checking your connection to prevent automated abuse Why am I seeing this? Having problems? Contact support